Cyclerion Therapeutics Announces Merger with Korsana Biosciences
Acquiring Company
Cyclerion Therapeutics
Acquired Company
Korsana Biosciences
CambridgeWalthamBiotechnologyHealthcareHealth CareTherapeuticsBiotechnologyHealth CareTherapeuticsDescription
On August 25, 2026, Cyclerion Therapeutics, Inc. announced that its board of directors fixed the close of business on September 4, 2026, as the record date for the distribution of contingent value rights in connection with its planned merger with Korsana Biosciences, Inc. This announcement marks a significant development in Cyclerion's strategic expansion efforts. The merger is anticipated to enhance Cyclerion's capabilities and broaden its therapeutic portfolio.
Don't miss Cyclerion Therapeutics's next move
Get an email the moment Cyclerion Therapeutics makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Korsana Biosciences?
Korsana Biosciences was acquired by Cyclerion Therapeutics, based in Cambridge. The deal was reported on August 25, 2026. Cyclerion Therapeutics is a clinical-stage biopharmaceutical company. Cyclerion Therapeutics is publicly traded (CYCN) and operates in Biotechnology.
When did Cyclerion Therapeutics acquire Korsana Biosciences?
Cyclerion Therapeutics's acquisition of Korsana Biosciences was reported on August 25, 2026. On August 25, 2026, Cyclerion Therapeutics, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Korsana Biosciences do?
Korsana Biosciences, Inc. is a biotechnology company focused on discovering and developing novel therapies for neurodegenerative diseases, particularly Alzheimer's disease. It is privately held, operating in Biotechnology, and is based in Waltham.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.